The new 150mg oral pellet formulation provides a capsule-free prophylactic option for adults and adolescents with hereditary ...
The investigational vaccine targets pathological amyloid-beta to lower brain amyloid in patients with preclinical Alzheimer ...
Mean percentage of time that CGM-measured glucose level was in range of 70 to 180mg/dL was 21 percentage points higher with CGM ...
Strong recommendations include distinguishing bothersome from nonbothersome tinnitus, asking about risks for self-harm.
HealthDay News — Antipsychotic treatment initiation is associated with rapid increases in hemoglobin A1c (HbA1c) and weight, according to a study published in the November issue of The Lancet ...
Patients with baseline viral suppression maintained viral suppression, while those without achieved viral suppression by 13 ...
Tizanidine HCl 4mg (quadrisecting score). Initially 2mg; may repeat every 6–8hrs as needed, up to max 3 doses in 24hrs. May increase gradually by 2–4mg, with 1–4 days between dose increases; max ...
The newly approved autoinjector provides an alternative to the prefilled syringe for daily self-administration.
Strong recommendations made for semiannual surveillance for HCC, testing and vaccination for hepatitis A and B.
Accelerated approval is supported by 34-week interim data from the phase 3 I CAN trial showing a statistically significant 43% placebo-adjusted reduction in proteinuria.
The FDA has granted over-the-counter approval to Brytly (apraclonidine ophthalmic solution 0.125%) for the symptomatic relief of eye redness due to minor irritation in individuals aged 12 years and ...
Real-world data from Fall Clinical 2026 reveal widespread treatment dissatisfaction, anxiety, and steroid hesitancy among ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results